Neuroprotective effects of PPARα in retinopathy of type 1 diabetes.

Diabetic retinopathy (DR) is a common neurovascular complication of type 1 diabetes. Current therapeutics target neovascularization characteristic of end-stage disease, but are associated with significant adverse effects. Targeting early events of DR such as neurodegeneration may lead to safer and m...

Full description

Bibliographic Details
Main Authors: Elizabeth A Pearsall, Rui Cheng, Satoshi Matsuzaki, Kelu Zhou, Lexi Ding, Bumsoo Ahn, Michael Kinter, Kenneth M Humphries, Alexander B Quiambao, Rafal A Farjo, Jian-Xing Ma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0208399